Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...
The FDAapproval for sleep apnea is ... That equates to 45 to 50 pounds of weightloss, on average, over a year, Lilly said. Patients on the drug also saw reductions in blood pressure and ...